April 10, 2022 – Sotrovimab, sold under the brand name Xevudy, is a monoclonal antibody that was available under emergency use authorization (EUA) from the FDA and similar urgency authorisations from several drug regulatory agencies worldwide for the treatment of patients …

SARS-CoV-2 Delta Variant: Resistance Mutations after Sotrovimab Use Read more »